Pulmonary embolism in patients with cancer
Article Sidebar
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Main Article Content
https://orcid.org/0000-0003-4105-1915
Abstract
The aim – to study the structure of cancer, its age and gender characteristics among patients with pulmonary embolism (PE) in the context of an oncological process.
Materials and methods. A total of 647 patients with PE were examined, among whom 105 patients (16 %) had acute pulmonary artery thrombosis associated with malignant disease. Since some patients were diagnosed with an advanced metastatic stage during the examination, making it impossible to determine the primary tumor site, they were excluded from further analysis (3 patients, 2.8 %).
Results. Analysis of cancer structure among patients with PE showed that solid tumors significantly prevailed over hematologic malignancies. The three most common cancer localizations were breast cancer (21.9 %), prostate cancer (17.1 %), kidney cancer (14.3 %), and colorectal cancer (12.4 %).
Conclusions. The most common cancer localizations among patients with PE are breast and prostate cancer. Gender differences and cancer localization influence the clinical manifestations and course of PE.
Article Details
Keywords:
References
Falanga A, Ay C, Di Nisio M, Gerotziafas G, Jara-Palomares L, Langer F, et al. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline. Ann Oncol. 2023 May;34(5):452-467. https://doi.org/10.1016/j.annonc.2022.12.014
Agnelli G. Venous thromboembolism and cancer: a two-way clinical association. Thromb Haemost. 1997 Jul;78(1):117-20. PMID: 9198139. https://pubmed.ncbi.nlm.nih.gov/9198139/
Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jiménez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Ní Áinle F, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020 Jan 21;41(4):543-603. https://doi.org/10.1093/eurheartj/ehz405
Tseluyko VY, Yakovleva LM, Sukhova SM, Kinoshenko KYu, Radchenko OV, Vnukova AS. Clinical and anamnestic characteristics and risk factors in patients with acute pulmonary embolism among residents of Kharkiv. Medytsyna nevidkladnykh staniv [Emergency Medicine (Ukraine)]. 2021;17(3):58-63. https://doi.org/10.22141/2224-0586.17.3.2021.234810. Ukrainian
Tseluyko VY, Kurinna MV, Yakovleva LM. The level of C-reactive protein in patients with acute pulmonary embolism. Medytsyna nevidkladnykh staniv [Emergency Medicine (Ukraine)]. 2023;19(5):322-31. https://doi.org/10.22141/2224-0586.19.5.2023.1607. Ukrainian
Tseluyko VY, Yakovleva LM, Askierov RN, Kurinna MV, Kharchenko LV, Shylo NG. Risk stratification of poor short-term prognosis in patients with high-risk pulmonary embolism. Medytsyna nevidkladnykh staniv [Emergency Medicine (Ukraine)]. 2023;19(5):361-9. https://doi.org/10.22141/2224-0586.19.5.2023.1612. Ukrainian
Catella-Chatron J, Merah A, De Magalhaes E, Moulin N, Accassat S, Duvillard C, et al. Suspicion of chronic thromboembolic pulmonary hypertension after pulmonary embolism in cancer patients. Respir Med Res. 2019 Nov;76:34-7. https://doi.org/10.1016/j.resmer.2019.08.002
Shalaby K, Kahn A, Silver ES, Kim MJ, Balakumaran K, Kim AS. Outcomes of acute pulmonary embolism in hospitalized patients with cancer. BMC Pulm Med. 2022 Jan 6;22(1):11. https://doi.org/10.1186/s12890-021-01808-9.
Mulder FI, Horváth-Puhó E, van Es N, van Laarhoven HWM, Pedersen L, Moik F, et al. Venous thromboembolism in cancer patients: a population-based cohort study. Blood. 2021 Apr 8;137(14):1959-69. https://doi.org/10.1182/blood.2020007338
Jakobsen SS, Frøkjaer JB, Fisker RV, Kristensen SR, Thorlacius-Ussing O, Larsen AC. Monocyte recruitment in venous pulmonary embolism at time of cancer diagnosis in upper gastrointestinal cancer patients. J Thromb Thrombolysis. 2024 Jan;57(1):11-20. https://doi.org/10.1007/s11239-023-02897-5
Zuin M, Nohria A, Henkin S, Krishnathasan D, Sato A, Piazza G. Pulmonary embolism-related mortality in patients with cancer. JAMA Netw Open. 2025 Feb 3;8(2):e2460315. https://doi.org/10.1001/jamanetworkopen.2024.60315.
Nouhravesh N, Strange JE, Sindet-Pedersen C, Holt A, Tønnesen J, Andersen CF, Nielsen SK, Grove EL, Nielsen D, Schou M, Lamberts M. Impact of breast, gastrointestinal, and lung cancer on prognosis in patients with first-time pulmonary embolism: a Danish nationwide cohort study. Int J Cardiol. 2024 Jul 1;406:132001. https://doi.org/10.1016/j.ijcard.2024.132001
Zhang YW, Tao R, Wu D, Ou JC, Kong ZC, Zhu ZZ. Research progress on the association between lung cancer and pulmonary embolism. J Cardiothorac Surg. 2025 Jan 3;20(1):2. https://doi.org/10.1186/s13019-024-03321-6
Kozhukhov SM, Dovhanych NV, Smolanka II, Kryachok IA, Lyhyrda OF. Prevention and treatment of venous thromboembolism in patients with oncopathology: a draft of clinical guidelines. Ukrainian J Cardiol. 2020;27(3):75-88. https://doi.org/10.31928/1608-635X-2020.3.7588
Tatsumi K. The pathogenesis of cancer-associated thrombosis. J Hematol. 2024 May;119(5):495-504. https://doi.org/10.1007/s12185-024-03735-x
Peseski AM, Kapoor S, Kuchibhatla M, Adamski A, Abe K, Beckman MG, Reyes NL, Richardson LC, Saber I, Schulteis R, Singh BP, Sitlinger A, Thames EH, Ortel TL. An epidemiologic study comparing cancer- and noncancer-associated venous thromboembolism in a racially diverse Southeastern United States county. Res Pract Thromb Haemost. 2024 Apr 26;8(4):102420. https://doi.org/10.1016/j.rpth.2024.102420
Peseski AM, Kapoor S, Kuchibhatla M, Adamski A, Abe K. Occult cancer in patients with unprovoked venous thromboembolism: a nested case-control study. Am J Clin Pathol. 2024 Feb;161(2). https://doi.org/10.1093/ajcp/aqad178.
Sánchez-López V, Rodríguez-Arias J, Martín-López A, et al. Differential biomarker profiles between unprovoked venous thromboembolism and cancer. Ann Med. 2020 Jul;52(6):1-26. https://doi.org/10.1080/07853890.2020.1779956.
Sánchez-López V, Rodríguez-Arias J, Martín-López A, et al. Differential expression of plasma microRNAs in chronic thromboembolic pulmonary hypertension and pulmonary embolism related to occult cancer. Eur Respir J. 2021 Sep. https://doi.org/10.1183/13993003.congress-2021.PA593.
Strang P, Schultz T. High Rate of Thromboembolic Events in the Last Year of Life of Cancer Patients: A Registry Study. Cancers (Basel). 2024 Dec 1;16(23):4031. https://doi.org/10.3390/cancers16234031.
Xu Y, Wu T, Ren X, Liu J, Zhang H, Yang D, et al. Prevalence and clinical characteristics of venous thromboembolism in patients with lung cancer: a systematic review and meta-analysis. Front Oncol. 2024 Aug 14;14:1405147. https://doi.org/10.3389/fonc.2024.1405147.